Organisation paid for research Program year 2021 Source: CMS Open Payments

Baptist Heart Specialists

Neither a doctor nor a teaching hospital

Research payments

$37,998

30 payments

Through program year 2021, Baptist Heart Specialists is reported as receiving $37,998 in research payments, across 30 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$27,899	23
2020	Research	$2,204	4
2019	Research	$7,895	3

Breakdown

Who paid Research payments · program years 2019–2021

Amgen Inc. $23,635 6 payments
Novo Nordisk AS $6,393 20 payments
AstraZeneca Pharmaceuticals LP $6,015 1 payment
Bayer HealthCare Pharmaceuticals Inc. $1,955 3 payments

Studies the money was for Research payments · program years 2019–2021

Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9i (cvMOBIUS) $13,445 1 payment
(GOULD): a Registry of High Cardiovascular Risk Subjects in the United States $10,190 5 payments
Ex9536-4773 $6,393 20 payments
Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes $6,015 1 payment
BAY59-7939 prevention of CV events in vascular disease $1,955 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.